The Who, Where, and How of Regulating AI
By Eliza Strickland,
IEEE Spectrum
| 06. 14. 2023
During the past year, perhaps the only thing that has advanced as quickly as artificial intelligence is worry about artificial intelligence.
In the near term, many fear that chatbots such as OpenAI’s ChatGPT will flood the world with toxic language and disinformation, that automated decision-making systems will discriminate against certain groups, and that the lack of transparency in many AI systems will keep problems hidden. There’s also the looming concern of job displacement as AI systems prove themselves capable of matching or surpassing human performance. And in the long term, some prominent AI researchers fear that the creation of AI systems that are more intelligent than humans could pose an existential risk to our species.
The technology’s rapid advancement has brought new urgency to efforts around the world to regulate AI systems. The European Union got started first, and this week, on 14 June, took a step forward when one of its institutions, the European Parliament, voted to advance the draft legislation known as the AI Act. But China’s rule-makers have been moving the quickest to turn proposals into real...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...